volume 27, issue 2, P181-186 2013
DOI: 10.3109/02688697.2012.757293
View full text
|
Sign up to set email alerts
|
Share

Abstract: There was benefit of simvastatin in terms of reduction in clinical vasospasm, mortality or improved functional outcome, however, this was not statistically significant.